These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30615863)

  • 1. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.
    Radogna F; Diederich M
    Biochem Pharmacol; 2018 Jul; 153():12-23. PubMed ID: 29438676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment.
    Yang LJ; Han T; Liu RN; Shi SM; Luan SY; Meng SN
    Biomed Pharmacother; 2024 Aug; 177():117099. PubMed ID: 38981240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Sep; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural compound inducers of immunogenic cell death.
    Diederich M
    Arch Pharm Res; 2019 Jul; 42(7):629-645. PubMed ID: 30955159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy.
    Yan C; Zhao Y; Liu X; Jiang Y; Li Q; Yang L; Li X; Luo K
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33169-33181. PubMed ID: 38915234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapy.
    Zhang J; Chen J; Lin K
    Eur J Pharmacol; 2024 Oct; 981():176913. PubMed ID: 39154830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
    Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
    Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
    Hiep Tran T; Thu Phuong Tran T
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113085. PubMed ID: 39276455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.
    Qi H; Li Y; Geng Y; Wan X; Cai X
    Int J Pharm; 2024 May; 656():124045. PubMed ID: 38561134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tartrolon D induces immunogenic cell death in melanoma.
    Brito TL; Edson EA; Dias Florêncio KG; Machado-Neto JA; Garnique ADMB; Mesquita Luiz JP; Cunha FQ; Alves-Filho JC; Haygood M; Wilke DV
    Chem Biol Interact; 2024 Sep; 400():111177. PubMed ID: 39097071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide-Based K
    Lee D; Ha J; Ahn H; Jeong SD; Jeong M; Park JH; Yun CO; Kim YC
    ACS Appl Bio Mater; 2021 Dec; 4(12):8333-8342. PubMed ID: 35005917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
    Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
    Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
    Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
    Inoue H; Tani K
    Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.
    Amiri M; Molavi O; Sabetkam S; Jafari S; Montazersaheb S
    Cancer Cell Int; 2023 Sep; 23(1):200. PubMed ID: 37705051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
    Aria H; Rezaei M
    Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.